Market Research Logo

Immunohematology - Medical Devices Pipeline Assessment, 2018

Immunohematology - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Immunohematology - Medical Devices Pipeline Assessment, 2018 provides an overview of Immunohematology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunohematology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunohematology under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunohematology and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunohematology under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Immunohematology Overview
3 Products under Development
3.1 Immunohematology - Pipeline Products by Stage of Development
3.2 Immunohematology - Pipeline Products by Segment
3.3 Immunohematology - Pipeline Products by Territory
3.4 Immunohematology - Pipeline Products by Regulatory Path
3.5 Immunohematology - Pipeline Products by Estimated Approval Date
4 Immunohematology - Pipeline Products under Development by Companies
4.1 Immunohematology Companies - Pipeline Products by Stage of Development
4.2 Immunohematology - Pipeline Products by Stage of Development
5 Immunohematology Companies and Product Overview
5.1 AbSorber AB Company Overview
5.2 Amity University Company Overview
5.3 Arizona State University Company Overview
5.4 Biofortuna Ltd Company Overview
5.5 Grifols SA Company Overview
5.6 Haemonetics Corp Company Overview
5.7 Immucor, Inc. Company Overview
5.8 Ortho-Clinical Diagnostics Inc Company Overview
5.9 Quotient Limited Company Overview
5.10 TBG Diagnostics Ltd Company Overview
5.11 Transfusion & Transplantation Technologies (Inactive) Company Overview
6 Immunohematology- Recent Developments
6.1 Jun 18, 2018: Quotient Reports Concordance Data from the MosaiQ European Field Trial
6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers
6.3 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics
6.4 May 29, 2018: Quotient Names Franz Walt As Chief Executive Officer
6.5 May 29, 2018: Quotient Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Updates on CEO Appointment and MosaiQ European Field Trials
6.6 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends
6.7 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency
6.8 May 17, 2018: Quotient Reports Commencement of EU Blood Grouping Field Trial
6.9 May 15, 2018: Prenatal testing of the foetal rhesus factor: test is reliable, but benefit is unclear
6.10 May 14, 2018: Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
6.11 May 08, 2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer
6.12 May 08, 2018: Bio-Rad Announces First Quarter 2018 Financial Results
6.13 May 08, 2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance
6.14 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future
6.15 May 03, 2018: Siemens Healthineers fully on track to meet the targets
6.16 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales
6.17 Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018
6.18 Mar 28, 2018: Medix Biochemica Launch NT-proBNP antibody 1309 available
6.19 Mar 26, 2018: Quotient Reports Blood Grouping Concordance Data From MosaiQ Verification and Validation Studies and Updates on the Completion of Its Sale Leaseback Transaction
6.20 Mar 26, 2018: Quotient Announces Retirement of Paul Cowan, Chairman and Chief Executive Officer; Franz Walt Named as Interim Chief Executive Officer
6.21 Feb 27, 2018: Bio-Rad Reports Fourth-Quarter and Full-Year 2017 Financial Results
6.22 Feb 20, 2018: Quotient Announces Appointment of Franz Walt as Non-Executive Director
6.23 Feb 20, 2018: Quotient Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility
6.24 Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017
6.25 Feb 06, 2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings
6.26 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics
6.27 Jan 25, 2018: Ellen M. Zane Rejoins Haemonetics Board of Directors
6.28 Jan 16, 2018: Avi Pelossof Appointed President and CEO of Immucor
6.29 Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech
6.30 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange
6.31 Nov 02, 2017: Grifols increases its revenues by 10% to Euros 3,250 million and grows net profit by 6.3% to reach Euros 432 million
6.32 Nov 02, 2017: Bio-Rad Reports Third-Quarter 2017 Financial Results
6.33 Oct 30, 2017: Quotient Reports Second Quarter Fiscal 2018 Financial Results
6.34 Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017
6.35 Oct 24, 2017: SYGNIS announces the launch of the Universal Lateral Flow Assay kit and associated patent filing
6.36 Oct 18, 2017: Robert E. Abernathy Joins Haemonetics Board of Directors
6.37 Oct 02, 2017: Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting
6.38 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results
6.39 Sep 12, 2017: Quotient Reports Results From Latest MosaiQ Performance Evaluation Studies involving MosaiQ IH Microarray
6.40 Aug 07, 2017: Quotient Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results
6.41 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results
6.42 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions
6.43 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9%
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Immunohematology - Pipeline Products by Stage of Development
Table 2: Immunohematology - Pipeline Products by Segment
Table 3: Immunohematology - Pipeline Products by Territory
Table 4: Immunohematology - Pipeline Products by Regulatory Path
Table 5: Immunohematology - Pipeline Products by Estimated Approval Date
Table 6: Immunohematology Companies - Pipeline Products by Stage of Development
Table 7: Immunohematology - Pipeline Products by Stage of Development
Table 8: AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ABO Diagnostic Test - Product Status
Table 10: ABO Diagnostic Test - Product Description
Table 11: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Blood Group Testing Kit - Product Status
Table 13: Blood Group Testing Kit - Product Description
Table 14: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Blood Screening Immunosignaturing - Product Status
Table 16: Blood Screening Immunosignaturing - Product Description
Table 17: Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: HemoPlex Kell Genotyping Kit - Product Status
Table 19: HemoPlex Kell Genotyping Kit - Product Description
Table 20: HemoPlex Kidd & Duffy Genotyping Kit - Product Status
Table 21: HemoPlex Kidd & Duffy Genotyping Kit - Product Description
Table 22: HemoPlex MNS Genotyping Kit - Product Status
Table 23: HemoPlex MNS Genotyping Kit - Product Description
Table 24: HemoPlex Multi Blood Group Genotyping Kit - Product Status
Table 25: HemoPlex Multi Blood Group Genotyping Kit - Product Description
Table 26: HemoPlex RHCE Screening Kit - Product Status
Table 27: HemoPlex RHCE Screening Kit - Product Description
Table 28: HemoPlex RHCE Variant Genotyping Kit - Product Status
Table 29: HemoPlex RHCE Variant Genotyping Kit - Product Description
Table 30: HemoPlex RHD & CE Genotyping Kit - Product Status
Table 31: HemoPlex RHD & CE Genotyping Kit - Product Description
Table 32: HemoPlex RHD Variant Genotyping Kit - Product Status
Table 33: HemoPlex RHD Variant Genotyping Kit - Product Description
Table 34: ThromboPlex HPA Screening Kit - Product Status
Table 35: ThromboPlex HPA Screening Kit - Product Description
Table 36: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
Table 37: IH Blood Genotyping (D) Kit - Product Status
Table 38: IH Blood Genotyping (D) Kit - Product Description
Table 39: Haemonetics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Blood Typing System - Product Status
Table 41: Blood Typing System - Product Description
Table 42: Immucor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 43: NEO Iris - Product Status
Table 44: NEO Iris - Product Description
Table 45: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: ORTHO AutoVue - Rare Sera Assay - Product Status
Table 47: ORTHO AutoVue - Rare Sera Assay - Product Description
Table 48: ORTHO BioVue - Rare Sera Assay - Product Status
Table 49: ORTHO BioVue - Rare Sera Assay - Product Description
Table 50: Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 51: ALBAclone Anti-C beta Reagent - Product Status
Table 52: ALBAclone Anti-C beta Reagent - Product Description
Table 53: ALBAclone Anti-e beta Reagent - Product Status
Table 54: ALBAclone Anti-e beta Reagent - Product Description
Table 55: ALBAclone Anti-H Reagent - Product Status
Table 56: ALBAclone Anti-H Reagent - Product Description
Table 57: ALBAcyte O Adult i Cell Reagent - Product Status
Table 58: ALBAcyte O Adult i Cell Reagent - Product Description
Table 59: ALBAcyte O RhD VI Reagent Cells - Product Status
Table 60: ALBAcyte O RhD VI Reagent Cells - Product Description
Table 61: Eluate Kit - Product Status
Table 62: Eluate Kit - Product Description
Table 63: MosaiQ IH Microarray - Product Status
Table 64: MosaiQ IH Microarray - Product Description
Table 65: Polyagglutionation Kit - Product Status
Table 66: Polyagglutionation Kit - Product Description
Table 67: Sensitivity Kit Anti-S, K, e, C - Product Status
Table 68: Sensitivity Kit Anti-S, K, e, C - Product Description
Table 69: TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 70: HLAssure SE A Locus SBT Kit - Product Status
Table 71: HLAssure SE A Locus SBT Kit - Product Description
Table 72: HLAssure SE B Locus SBT Kit - Product Status
Table 73: HLAssure SE B Locus SBT Kit - Product Description
Table 74: HLAssure SE C Locus SBT Kit - Product Status
Table 75: HLAssure SE C Locus SBT Kit - Product Description
Table 76: HLAssure SE DQB Locus SBT Kit - Product Status
Table 77: HLAssure SE DQB Locus SBT Kit - Product Description
Table 78: HLAssure SE DRB-EX Locus SBT Kit - Product Status
Table 79: HLAssure SE DRB-EX Locus SBT Kit - Product Description
Table 80: Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Aegis - Anti-A Quantitation In Group O Platelets - Product Status
Table 82: Aegis - Anti-A Quantitation In Group O Platelets - Product Description
Table 83: Aegis - Antibody Screening And Identification Assay - Product Status
Table 84: Aegis - Antibody Screening And Identification Assay - Product Description
Table 85: Aegis - Blood Grouping Assay - Product Status
Table 86: Aegis - Blood Grouping Assay - Product Description
Table 87: Aegis - Platelet Cross-match Assay - Product Status
Table 88: Aegis - Platelet Cross-match Assay - Product Description
Table 89: Aegis - Residual A Quantitation Assay - Product Status
Table 90: Aegis - Residual A Quantitation Assay - Product Description
Table 91: Aegis - rWBC Quantitation Assay - Product Status
Table 92: Aegis - rWBC Quantitation Assay - Product Description
Table 93: AEGIS System - Product Status
Table 94: AEGIS System - Product Description
Table 95: Glossary
1.2 List of Figures
Figure 1: Immunohematology - Pipeline Products by Stage of Development
Figure 2: Immunohematology - Pipeline Products by Segment
Figure 3: Immunohematology - Pipeline Products by Territory
Figure 4: Immunohematology - Pipeline Products by Regulatory Path
Figure 5: Immunohematology - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report